Cleerly ISCHEMIA vs Imbio RV/LV Software
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly ISCHEMIA is designed for non-invasive detection of coronary artery ischemia and plaque characterization using CCTA scans, aiding in heart disease diagnosis. In contrast, Imbio RV/LV Software focuses on automatically measuring right and left ventricular diameters from CTPA scans to assist in risk stratification for pulmonary conditions such as pulmonary embolism. While both are AI tools for cardiac imaging, their distinct clinical applications and target pathologies make them complementary rather than directly competitive.
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive evaluation of coronary artery disease from CCTA scans. This tool is ideal for precisely characterizing coronary plaque, assessing stenosis severity, and determining vessel-level ischemia likelihood to inform personalized treatment strategies for heart disease patients.
View Cleerly ISCHEMIA →Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if you need an automated, rapid assessment of right and left ventricular dimensions from CTPA scans. This tool is best suited for quickly calculating the RV/LV ratio to aid in risk stratification for patients with suspected or confirmed pulmonary conditions, such as pulmonary embolism, where ventricular strain is a key prognostic factor.
View Imbio RV/LV Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | Imbio RV/LV Software |
|---|---|---|
| Pricing | Contact for details | Unknown |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | Imbio RV/LV Software |
|---|---|---|
| Tool Name | Cleerly ISCHEMIA | Imbio RV/LV Software |
| Company | Cleerly | Imbio |
| Description | Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | Imbio RV/LV Software is an AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
| Key Features | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API. | Automated measurement of right and left ventricular diameters, Calculation and reporting of RV/LV ratio, Artificial intelligence algorithm for ventricle identification and measurement, Provides annotated images showing ventricular measurements, Generates summary PDF reports, Fully automated workflow, no user intervention required after scan completion, DICOM compliant input and output, Integration with standard reading environments (PACS). |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Imbio RV/LV Software.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. Imbio RV/LV Software is an AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism.
Cleerly ISCHEMIA requires CCTA (Coronary CT Angiography) scans for its analysis. Imbio RV/LV Software utilizes CTPA (CT Pulmonary Angiography) scans to perform its automated ventricular measurements.
Cleerly ISCHEMIA provides AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, and coronary plaque characterization (volume, type, location). It also offers stenosis severity assessment and 3D digital models of coronary arteries. Imbio RV/LV Software offers automated measurement of right and left ventricular diameters, calculation and reporting of the RV/LV ratio, and annotated images showing these measurements. It generates summary PDF reports for its findings.
Cleerly ISCHEMIA primarily supports Cardiology and Radiology specialties. Imbio RV/LV Software supports Cardiology, Pulmonology, and Radiology specialties.
Cleerly ISCHEMIA provides comprehensive interactive web-based reports and integrates with PowerScribe via API. Imbio RV/LV Software features a fully automated workflow with DICOM compliant input and output, and integrates with standard reading environments such as PACS.
More Comparisons
More matchups featuring Cleerly ISCHEMIA or Imbio RV/LV Software
Backers
Who funded each tool's parent company.